Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

N-Cyclohexylmethylone

From Wikipedia, the free encyclopedia
(Redirected from Cyputylone)
N-Cyclohexylmethylone
Clinical data
Other namesCybutylone
Legal status
Legal status
  • DE: Anlage II (Authorized trade only, not prescriptible)
  • UK: Class B
  • US: Unscheduled, schedule I in Virginia[1]
Identifiers
  • 1-(Benzo[d][1,3]dioxol-5-yl)-2-(cyclohexylamino)propan-1-one
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H21NO3
Molar mass275.348 g·mol−1
3D model (JSmol)
  • CC(C(=O)C1=CC2=C(C=C1)OCO2)NC3CCCCC3
  • InChI=1S/C16H21NO3/c1-11(17-13-5-3-2-4-6-13)16(18)12-7-8-14-15(9-12)20-10-19-14/h7-9,11,13,17H,2-6,10H2,1H3
  • Key:WZDQUORQDHVTKD-UHFFFAOYSA-N

N-Cyclohexylmethylone (cyputylone) is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug. It was first identified in the United States in 2022.[2][3]

See also

[edit]

References

[edit]
  1. "§ 54.1-3446. Schedule I." Virginia Law. Retrieved 14 September 2023.
  2. CFSRE (2022) N-Cyclohexyl methylone
  3. Kuropka P, Zawadzki M, Szpot P (September 2022). "A review of synthetic cathinones emerging in recent years (2019-2022)". Forensic Toxicology. 41 (1): 25–46. doi:10.1007/s11419-022-00639-5. PMC 9476408. PMID 36124107.